- S&P 5007,561.67−0.40%
- Nasdaq 10027,943.74−1.22%
- NVDA$162.85−2.01%
- AAPL$356.27+0.39%
- MSFT$523.88+0.17%
- GOOGL$295.77−0.98%
- AMZN$266.66−0.29%
- META$641.69+2.90%
- TSLA$390.22−1.82%
- AVGO$347.01−4.76%
- AMD$534.06−8.75%
- MU$778.31−2.52%
Stock news
317 stories
Market narrative auditsFluence Energy, Inc. (NASDAQ: FLNC) Cuts 2026 Revenue OutlookHouston production delays cut the revenue target to $2.4 billion. The expected adjusted EBITDA loss widened to about $200 million. FLNC · OptimistFi Research Desk · 
Investor guidesWhy Is Adobe Inc. (NASDAQ: ADBE) Stock Down 26% This Year?Sales are growing, but the shift toward free AI tools creates a harder question: how many new users will become paying customers? ADBE · OptimistFi Research Desk · 
Market narrative auditsClark Square Capital Highlights LuxExperience B.V. (NYSE: LUXE) Buyback PotentialThe investor spotted why a $50 million buyback could matter more than it first appears. Our ownership calculation puts its scale at nearly a quarter of estimated float. LUXE · OptimistFi Research Desk · 
Market narrative auditsPulse Biosciences, Inc. (NASDAQ: PLSE) Lines Up Cash for Its Next Clinical TestsAn $85 million share-sale program could fund development as a thyroid study reaches full enrollment. Shareholders need to weigh that progress against dilution. PLSE · OptimistFi Research Desk · 
Market narrative auditsJ.B. Hunt Transport Services, Inc. (NASDAQ: JBHT) Faces a Costly Growth PushHiring and fuel are adding at least $35 million of pressure. Management expects more freight to soften the hit, but still sees earnings falling. JBHT · OptimistFi Research Desk · 
Market narrative auditsCo-Diagnostics, Inc. (NASDAQ: CODX) Pursues Blood Tests With Cash in FocusAn Ebola testing project could broaden the platform’s reach. The next hurdles are proving it works and paying for development. CODX · OptimistFi Research Desk · 
Investment case changesHuntington Bancshares Incorporated (NASDAQ: HBAN) Cuts Its 2027 Profit TargetSlower lending and weaker margins have lowered the bank’s ambitions. A larger planned buyback could cushion earnings per share. HBAN · OptimistFi Research Desk · 
Market narrative auditsOscar Health, Inc. (NYSE: OSCR) Raises Profit Outlook AgainThe insurer lifted its annual profit forecast. Subtract first-half earnings, however, and the new range still implies a second-half operating loss. OSCR · OptimistFi Research Desk · 
Market narrative auditsFTAI Aviation Ltd. (NASDAQ: FTAI) Buyback Puts Cash Flow in FocusThe $500 million authorization exceeds June cash, but management has three years to act. Engine spending will help determine how much it can buy. FTAI · OptimistFi Research Desk · 
Investor guidesWhy Is Micron Technology, Inc. (NASDAQ: MU) Stock Up 225% This Year?Micron Technology, Inc. (NASDAQ: MU) has turned rising memory demand into much higher sales and margins. The next question is how long those profits can last. MU · OptimistFi Research Desk · 
Market narrative auditsBowman Consulting Group Ltd. (NASDAQ: BWMN) Gets No Rival Buyout BidsBowman Consulting Group Ltd. (NASDAQ: BWMN) contacted 76 potential buyers without receiving another proposal. The agreed cash takeover still needs approvals. BWMN · OptimistFi Research Desk · 
Market narrative auditsThe Hain Celestial Group, Inc. (NASDAQ: HAIN) Plans Asset Sale to Cut DebtThe Hain Celestial Group, Inc. (NASDAQ: HAIN) expects up to $310 million in net sale proceeds. A lender agreement must come first. HAIN · OptimistFi Research Desk ·
FLNC · OptimistFi Research Desk · 
ADBE · OptimistFi Research Desk · 
LUXE · OptimistFi Research Desk · 
PLSE · OptimistFi Research Desk · 
JBHT · OptimistFi Research Desk · 
HBAN · OptimistFi Research Desk · 
OSCR · OptimistFi Research Desk · 
HAIN · OptimistFi Research Desk ·